Skip to main content

Perseris Prices, Coupons and Patient Assistance Programs

Perseris (risperidone) is a member of the atypical antipsychotics drug class and is commonly used for Schizophrenia.

The cost for Perseris subcutaneous powder for injection, extended release 90 mg is around $2,299 for a supply of 1 powder for injections, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Perseris prices

Subcutaneous Powder For Injection, Extended Release

Quantity Per unit Price
1 $2,298.84 $2,298.84

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Quantity Per unit Price
1 $3,061.98 $3,061.98

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Perseris Coupons, Copay Cards and Rebates

Perseris offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Perseris Insupport Copay Assistance Program

Eligible commercially insured patients may pay as little as $5 per injection; program exhausts after 13 doses or $8000 whichever comes first; eligibility period for the program is based on a calendar year; for additional information contact the program at 844-467-7778.

Applies to:
Perseris
Number of uses:
13 doses or $8000 whichever comes first program over a calendar year

Form more information phone: 844-467-7778 or Visit website

Patient Assistance & Copay Programs for Perseris

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Perseris (risperidone) Injection for Suspension; Extended-Release

More information please phone: 800-675-8416 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Perseris (risperidone) Injection for Suspension; Extended-Release

More information please phone: 866-316-7263 Visit Website

Provider: inSupport Patient Assistance Program: Perseris

Eligibility requirements:
  1. Must not have insurance
  2. Based on FPL
  3. FDA-approved diagnosis
  4. Must be residing in the US or a US territory, and under the care of a US physician
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility.
Applicable drugs:
  • Perseris (risperidone) Injection for Suspension; Extended-Release

More information please phone: 844-467-7778 Visit Website